ArticleJournal of the American Chemical Society2026
Targeted Synthesis of Durene from CO2 via a Tailored Coupling Reaction Pathway.
Article in Journal of the American Chemical Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
A precisely engineered coupling reaction pathway was developed over a rationally designed multifunctional oxide-zeolite catalyst for the highly selective transformation of CO2 to durene (1,2,4,5-tetramethylbenzene, termed 1,2,4,5-TeMB), a high-value-added aromatic compound. The detailed reaction pathway and dynamic structure evolution of the catalyst were unveiled through in situ diffuse reflectance infrared Fourier transform spectroscopy (DRIFTS), resonant Auger electron spectroscopy (RAS), in situ X-ray absorption fine structure spectroscopy (XAFS), and density functional theory (DFT) calculations. An optimal oxide catalyst featuring the tetragonal InZrOx solid solution structure was developed to match the thermodynamic characteristics of the CO2-to-aromatics reaction. It exhibits a spatial synergy between CO2 adsorption and H2 activation, therefore promoting CO2 hydrogenation via the HCOO* pathway at lower temperatures, which is thermodynamically essential for the formation of TeMBs over zeolites. For the selectivity control among several TeMB isomers, a ZSM-5 nanosheet zeolite with a b-axis dimension of subhundred nanometers was optimized. The presence of abundant surface acid sites and pore mouth confinement in these ZSM-5 nanosheets reinforces the pore mouth shape-selective methylation and precisely positions methyl substituents on benzene rings. Through efficiently coupling reaction processes of low-temperature CO2 hydrogenation, aromatization, and zeolite pore mouth shape-selective methylation, the InZrOx/ZSM-5 catalyst substantially narrows the C6-C12 aromatic distribution and achieves the targeted synthesis of durene, which accounts for 83.3% of the total aromatic products.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.